—

Takeda Pharmaceutical Co Ltd ADR (TAK) — the peer cohort

As of 2026-10-30 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Takeda Pharmaceutical Co Ltd ADR ranks 7 of 7 in its cohort on the Closelooknet composite (52/100) — the cohort is led by Lantheus Holdings Inc at 60/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
TAK Takeda Pharmaceutical Co Ltd ADR 52 82 40 80 ok 1.5%
LNTH Lantheus Holdings Inc 60 73 73 55 ok 10.2%
BHC.TO Bausch Health Companies Inc 58 86 71 83 info 9.3%
GALDY GALDERMA GROUP AG 57 71 59 23 ok 0.4%
KNSA Kiniksa Pharmaceuticals Ltd 57 97 59 19 ok 6.3%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 56 93 58 47 ok 0.8%
IRWD Ironwood Pharmaceuticals Inc 55 25 77 84 warn 39.4%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-30

Quick answers

Who are Takeda Pharmaceutical Co Ltd ADR's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Lantheus Holdings Inc (LNTH), Bausch Health Companies Inc (BHC.TO), GALDERMA GROUP AG (GALDY), Kiniksa Pharmaceuticals Ltd (KNSA), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), Ironwood Pharmaceuticals Inc (IRWD), as of 2026-10-30.

How does TAK score against its peers?

Takeda Pharmaceutical Co Ltd ADR's composite reads 52/100, ranking 7 of 7 in its cohort as of 2026-10-30; the cohort's highest composite is Lantheus Holdings Inc at 60/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.